表纸
市场调查报告书

血友病治疗的全球市场:各产品,疾病的各类型,治疗形态,各治疗法,各终端用户,地区的分析与预测

Hemophilia Treatment Market to 2027 - Global Analysis and Forecasts by Product, Disease, Treatment Type, Therapy, End User, and Geography

出版商 The Insight Partners 商品编码 928745
出版日期 内容资讯 英文 225 Pages
订单完成后即时交付
价格
血友病治疗的全球市场:各产品,疾病的各类型,治疗形态,各治疗法,各终端用户,地区的分析与预测 Hemophilia Treatment Market to 2027 - Global Analysis and Forecasts by Product, Disease, Treatment Type, Therapy, End User, and Geography
出版日期: 2020年02月28日内容资讯: 英文 225 Pages
简介

血友病,是血液的凝固受阻的遗传性的出血性疾病,主要的症状是在身体各部分的出血。全球血友病患者数,估计有40万人以上,不过,其中有约75%尚未诊断血友病,没有得到适切的治疗。血友病治疗相关的市场预计将从2019年的144亿5,481万美元扩大到2027年的440亿8,971万美元,从2020年到2027年的年复合成长率预计为15.9%。

本报告提供全球血友病治疗相关市场调查,市场概况和动态,各产品,各疾病类型,各治疗形态,各治疗法,各终端用户,各地区的市场分析,产业状况,企业简介等资讯。

目录

第1章 简介

  • 调查范围
  • Insight Partners调查报告的指导
  • 市场区隔

第2章 重要的要点

第3章 调查手法

  • 调查范围
  • 二次调查
  • 一次调查

第4章 市场概况

  • 概要
  • PEST分析
  • 专家的见解

第5章 市场力学

  • 成长促进因素
  • 成长阻碍因素
  • 市场机会
  • 今后趋势
  • 影响分析

第6章 全球市场分析

  • 世界市场收益预测与分析
  • 各地区市场预测与分析
  • 主要企业的立场

第7章 市场分析:各产品

  • 概要
  • 各产品的市场分析(2019年和2027年)
  • 血浆来源凝血因子浓缩制剂
  • 基因重组凝血因子浓缩制剂
  • 去氨加压素
  • 抗纤维溶解剂

第8章 市场分析:疾病的各类型

  • 概要
  • 疾病的各种类的市场分析 (2019年和2027年)
  • A型血友病
  • B型血友病
  • 血友病C

第9章 市场分析:各治疗形态

  • 概要
  • 各治疗形态的市场分析 (2019年和2027年)
  • 预防
  • 随选

第10章 市场分析:各治疗法

  • 概要
  • 各治疗法的市场分析 (2019年和2027年)
  • 补充疗法
  • 免疫耐受性诱导 (ITI) 疗法
  • 基因治疗

第11章 市场分析:各终端用户

  • 概要
  • 各终端用户的市场分析 (2019年和2027年)
  • 医院和诊疗所
  • 血友病治疗中心
  • 门诊外科手术中心

第12章 市场分析:各地区

  • 北美市场
  • 欧洲市场
  • 亚太地区市场
  • 中东、非洲市场
  • 中南美市场

第13章 产业情势

  • 概要
  • 各公司的成长策略(%)
  • 有机发展
  • 无机发展

第14章 企业简介

  • Bayer AG
  • Sanofi
  • F. Hoffmann-La Roche Ltd
  • Kedrion S.p.A
  • CSL Limited
  • Biotest AG.
  • Pfizer Inc.
  • Novo Nordisk A/S
  • Octapharma AG
  • Baxter International Inc.

第15章 附录

  • 关于 Insight Partners
  • 词汇表
目录
Product Code: TIPRE00008241

The global hemophilia treatment is expected to reach US$ 44,089.71 Mn in 2027 from US$ 14,454.81 Mn in 2019. The market is estimated to grow with a CAGR of 15.9% from 2020-2027.

The growth of the hemophilia treatment is primarily attributed to the factors such as increasing prevalence of hemophilia and rise in favorable government initiatives leading to launch of new products in the market. However, high cost related with hemophilia treatment is likely to pose a negative impact on the market growth. On the other hand, growth opportunities in emerging regions are likely to have a positive impact on the growth of the global hemophilia treatment during the forecast period.

Hemophilia is a hereditary bleeding disorder that stops the blood from clotting normally. The primary symptom is uncontrolled, often spontaneous bleeding in different areas of the body. According to data from the National Hemophilia Foundation in 2020, Hemophilia A happens in 1 in 5,000 live male births. Hemophilia A is about four times as common as hemophilia B. The number of people with hemophilia in the United States is anticipated to be around 20,000 individuals. Moreover, the incidence of hemophilia is not known across the globe but projected at above 400,000 people. Almost 75% of people with hemophilia worldwide are either undiagnosed or receive disparate treatment.

In Italy, according to the data of the National Center for Biotechnology Information (NCBI) in 2017, the number of registered people with bleeding disorders increased from about 7000 in 2000 to around 8500 in 2011 and more than 11,000 in 2015. The trend is due to an upsurge in the number of patients who are recorded, mainly in those with vWD type 1, mild hemophilia, or other factor deficiencies. Thus, increasing prevalence of hemophilia, high cases of under-diagnosed hemophilia cases, and improving healthcare infrastructure will eventually grow the market for hemophilia treatment in the forecast period.

Global hemophilia treatment, based on the product, is segmented into plasma derived coagulation factor concentrates plasma derived coagulation factor concentrates, desmopressin, antifibrinolytic agents. In 2019, the recombinant coagulation factor concentrates held the largest share of the market, by product. Also, recombinant coagulation factor concentrates segment is expected to grow at the fastest rate during the coming years owing to increasing adoption of integrated systems across the globe.

Some of the major primary and secondary sources for Hemostats included in the report are Centers for Disease Control and Prevention (CDC), USFDA, Central Intelligence Agency (CIA), National Clinical Database, and others.

Reasons to Buy

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the hemophilia treatment.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global hemophilia treatment, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution

Table of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Hemophilia Treatment Market - By Product
    • 1.3.2 Global Hemophilia Treatment Market - By Disease
    • 1.3.3 Global Hemophilia Treatment Market - By Treatment Type
    • 1.3.4 Global Hemophilia Treatment Market - By Therapy
    • 1.3.5 Global Hemophilia Treatment Market - By End User
    • 1.3.6 Global Hemophilia Treatment Market - By Geography

2. Global Hemophilia Treatment Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Hemophilia Treatment- Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America - PEST Analysis
    • 4.2.2 Europe: PEST Analysis
    • 4.2.3 APAC: PEST Analysis
    • 4.2.4 MEA: PEST Analysis
    • 4.2.5 South & Central America - PEST Analysis
  • 4.3 Expert Opinion

5. Hemophilia Treatment Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Prevalence of Hemophilia
    • 5.1.2 Rise in Favorable Government Initiatives
  • 5.2 Market Restraints
    • 5.2.1 High Cost Related with Hemophilia Treatment
  • 5.3 Market Opportunities
    • 5.3.1 Growth in the Global Healthcare Market
  • 5.4 Future Trends
    • 5.4.1 Research Activities and Product Innovations
  • 5.5 Impact Analysis

6. Hemophilia Treatment Market - Global Analysis

  • 6.1 Global Hemophilia Treatment Market Revenue Forecast And Analysis
  • 6.2 Global Hemophilia Treatment Market, By Geography - Forecast And Analysis
  • 6.3 Positioning of Key Players
    • 6.3.1 Bayer AG
    • 6.3.2 Pfizer Inc.

7. Global Hemophilia Treatment Market Analysis- by Product

  • 7.1 Overview
  • 7.2 Hemophilia Treatment Market Revenue Share, by Product (2019 and 2027)
  • 7.3 Plasma-Derived Coagulation Factor Concentrates
    • 7.3.1 Overview
    • 7.3.2 Plasma-Derived Coagulation Factor Concentrates: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
    • 7.3.3 Factor VIII
      • 7.3.3.1 Overview
      • 7.3.3.2 Factor VIII: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
    • 7.3.4 Factor IX
      • 7.3.4.1 Overview
      • 7.3.4.2 Factor IX: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
    • 7.3.5 Factor XII
      • 7.3.5.1 Overview
      • 7.3.5.2 Factor XII: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
    • 7.3.6 Activated Prothrombin Complex Concentrates
      • 7.3.6.1 Overview
      • 7.3.6.2 Activated Prothrombin Complex Concentrates: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
    • 7.3.7 Von Willebrand Factor
      • 7.3.7.1 Overview
      • 7.3.7.2 Von Willebrand Factor: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.4 Recombinant Coagulation Factor Concentrates
    • 7.4.1 Overview
    • 7.4.2 Recombinant Coagulation Factor Concentrates: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
    • 7.4.3 Factor VIII
      • 7.4.3.1 Overview
      • 7.4.3.2 Factor VIII: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
    • 7.4.4 Factor IX
      • 7.4.4.1 Overview
      • 7.4.4.2 Factor IX: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.5 Desmopressin
    • 7.5.1 Overview
    • 7.5.2 Desmopressin: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.6 Antifibrinolytic Agents
    • 7.6.1 Overview
    • 7.6.2 Antifibrinolytic Agents: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)

8. Hemophilia Treatment Market Analysis- by Disease

  • 8.1 Overview
  • 8.2 Hemophilia Treatment Market, by Disease 2019 and 2027 (%)
  • 8.3 Hemophilia A
    • 8.3.1 Overview
    • 8.3.2 Hemophilia A: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.4 Hemophilia B
    • 8.4.1 Overview
    • 8.4.2 Hemophilia B: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.5 Hemophilia C
    • 8.5.1 Overview
    • 8.5.2 Hemophilia C: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)

9. Hemophilia Treatment Market Analysis - by Treatment Type

  • 9.1 Overview
  • 9.2 Hemophilia Treatment Market Revenue Share, by Treatment Type (2019 and 2027)
  • 9.3 Prophylaxis
    • 9.3.1 Overview
    • 9.3.2 Prophylaxis: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • 9.4 On-demand
    • 9.4.1 Overview
    • 9.4.2 On-demand: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)

10. Hemophilia Treatment Market Analysis- by Therapy

  • 10.1 Overview
  • 10.2 Hemophilia Treatment Market, by Therapy 2019 and 2027 (%)
  • 10.3 Replacement Therapy
    • 10.3.1 Overview
    • 10.3.2 Replacement Therapy: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • 10.4 ITI Therapy
    • 10.4.1 Overview
    • 10.4.2 ITI Therapy: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • 10.5 Gene Therapy
    • 10.5.1 Overview
    • 10.5.2 Gene Therapy: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)

11. Hemophilia Treatment Market Analysis- by End User

  • 11.1 Overview
  • 11.2 Hemophilia Treatment Market, by End User 2019 and 2027 (%)
  • 11.3 Hospitals & Clinics
    • 11.3.1 Overview
    • 11.3.2 Hospitals & Clinics: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • 11.4 Hemophilia Treatment Centers
    • 11.4.1 Overview
    • 11.4.2 Hemophilia Treatment Centers: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • 11.5 Ambulatory Surgical Centers
    • 11.5.1 Overview
    • 11.5.2 Ambulatory Surgical Centers: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)

12. Hemophilia Treatment Market - Geographic Analysis

  • 12.1 North America: Hemophilia Treatment Market
    • 12.1.1 North America Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
    • 12.1.2 North America Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 12.1.2.1 North America Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 12.1.2.2 North America Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
    • 12.1.3 North America Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
    • 12.1.4 North America Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
    • 12.1.5 North America Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
    • 12.1.6 North America Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 12.1.7 North America Hemophilia Treatment Market, by Country, 2019 & 2027 (%)
    • 12.1.8 US Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
      • 12.1.8.1 US Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
      • 12.1.8.2 US Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
        • 12.1.8.2.1 US Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 12.1.8.2.2 US Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 12.1.8.3 US Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
      • 12.1.8.4 US Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
      • 12.1.8.5 US Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
      • 12.1.8.6 US Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 12.1.9 Canada Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
      • 12.1.9.1 Canada Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
      • 12.1.9.2 Canada Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
        • 12.1.9.2.1 Canada Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 12.1.9.2.2 Canada Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 12.1.9.3 Canada Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
      • 12.1.9.4 Canada Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
      • 12.1.9.5 Canada Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
      • 12.1.9.6 Canada Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 12.1.10 Mexico Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
      • 12.1.10.1 Mexico Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
      • 12.1.10.2 Mexico Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
        • 12.1.10.2.1 Mexico Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 12.1.10.2.2 Mexico Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 12.1.10.3 Mexico Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
      • 12.1.10.4 Mexico Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
      • 12.1.10.5 Mexico Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
      • 12.1.10.6 Mexico Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • 12.2 Europe: Hemophilia Treatment Market
    • 12.2.1 Overview
    • 12.2.2 Europe Hemophilia Treatment Market, Revenue and Forecast to 2027 (US$ Mn)
    • 12.2.3 Europe Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 12.2.3.1 Europe Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 12.2.3.2 Europe Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
    • 12.2.4 Europe Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
    • 12.2.5 Europe Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
    • 12.2.6 Europe Hemophilia Treatment Market, by Therapy- Revenue and Forecast to 2027 (USD Million)
    • 12.2.7 Europe Hemophilia Treatment Market, by End User- Revenue and Forecast to 2027 (USD Million)
    • 12.2.8 Europe Hemophilia Treatment Market, by Country, 2019 & 2027 (%)
    • 12.2.9 Germany Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
      • 12.2.9.1 Germany Hemophilia Treatment Market, Revenue and Forecast to 2027 (US$ Mn)
      • 12.2.9.2 Germany Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
        • 12.2.9.2.1 Germany Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 12.2.9.2.2 Germany Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 12.2.9.3 Germany Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
      • 12.2.9.4 Germany Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
      • 12.2.9.5 Germany Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
      • 12.2.9.6 Germany Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 12.2.10 UK Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
      • 12.2.10.1 UK Hemophilia Treatment Market, Revenue and Forecast to 2027 (US$ Mn)
      • 12.2.10.2 UK Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
        • 12.2.10.2.1 UK Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 12.2.10.2.2 UK Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 12.2.10.3 UK Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
      • 12.2.10.4 UK Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
      • 12.2.10.5 UK Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
      • 12.2.10.6 UK Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 12.2.11 France Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
      • 12.2.11.1 France Hemophilia Treatment Market, Revenue and Forecast to 2027 (US$ Mn)
      • 12.2.11.2 France Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
        • 12.2.11.2.1 France Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 12.2.11.2.2 France Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 12.2.11.3 France Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
      • 12.2.11.4 France Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
      • 12.2.11.5 France Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
      • 12.2.11.6 France Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 12.2.12 Spain Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
      • 12.2.12.1 Spain Hemophilia Treatment Market, Revenue and Forecast to 2027 (US$ Mn)
      • 12.2.12.2 Spain Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
        • 12.2.12.2.1 Spain Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 12.2.12.2.2 Spain Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 12.2.12.3 Spain Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
      • 12.2.12.4 Spain Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
      • 12.2.12.5 Spain Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
      • 12.2.12.6 Spain Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 12.2.13 Italy Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
      • 12.2.13.1 Italy Hemophilia Treatment Market, Revenue and Forecast to 2027 (US$ Mn)
      • 12.2.13.2 Italy Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
        • 12.2.13.2.1 Italy Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 12.2.13.2.2 Italy Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 12.2.13.3 Italy Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
      • 12.2.13.4 Italy Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
      • 12.2.13.5 Italy Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
      • 12.2.13.6 Italy Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • 12.3 APAC: Hemophilia Treatment Market
    • 12.3.1 Asia Pacific Hemophilia Treatment Market, Revenue and Forecast to 2027 (US$ Mn)
    • 12.3.2 Asia Pacific Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 12.3.2.1 Asia Pacific Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 12.3.2.2 Asia Pacific Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
    • 12.3.3 Asia Pacific Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
    • 12.3.4 Asia Pacific Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
    • 12.3.5 Asia Pacific Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
    • 12.3.6 Asia Pacific Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 12.3.7 Asia Pacific Hemophilia Treatment Market, by Country, 2019 & 2027 (%)
    • 12.3.8 Japan
      • 12.3.8.1 Japan Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
      • 12.3.8.2 Japan Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
        • 12.3.8.2.1 Japan Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 12.3.8.2.2 Japan Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 12.3.8.3 Japan Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
      • 12.3.8.4 Japan Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
      • 12.3.8.5 Japan Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
      • 12.3.8.6 Japan Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 12.3.9 China
      • 12.3.9.1 China Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
      • 12.3.9.2 China Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
        • 12.3.9.2.1 China Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 12.3.9.2.2 China Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 12.3.9.3 China Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
      • 12.3.9.4 China Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
      • 12.3.9.5 China Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
      • 12.3.9.6 China Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 12.3.10 India
      • 12.3.10.1 India Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
      • 12.3.10.2 India Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
        • 12.3.10.2.1 India Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 12.3.10.2.2 India Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 12.3.10.3 India Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
      • 12.3.10.4 India Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
      • 12.3.10.5 India Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
      • 12.3.10.6 India Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 12.3.11 South Korea
      • 12.3.11.1 South Korea Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
      • 12.3.11.2 South Korea Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
        • 12.3.11.2.1 South Korea Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 12.3.11.2.2 South Korea Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 12.3.11.3 South Korea Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
      • 12.3.11.4 South Korea Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
      • 12.3.11.5 South Korea Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
      • 12.3.11.6 South Korea Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 12.3.12 Australia
      • 12.3.12.1 Australia Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
      • 12.3.12.2 Australia Hemophilia Treatment Market, by Disease- Revenue and Forecast to 2027 (USD Million)
        • 12.3.12.2.1 Australia Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 12.3.12.2.2 Australia Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 12.3.12.3 Australia Hemophilia Treatment Market, by Disease- Revenue and Forecast to 2027 (USD Million)
      • 12.3.12.4 Australia Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
      • 12.3.12.5 Australia Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
      • 12.3.12.6 Australia Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • 12.4 Middle East & Africa: Hemophilia Treatment Market
    • 12.4.1 Overview
    • 12.4.2 Middle East & Africa Hemophilia Treatment Market, Revenue and Forecast to 2027 (US$ Mn)
    • 12.4.3 Middle East & Africa Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 12.4.3.1 Middle East & Africa Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 12.4.3.2 Middle East & Africa Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
    • 12.4.4 Middle East & Africa Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
    • 12.4.5 Middle East & Africa Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
    • 12.4.6 Middle East & Africa Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
    • 12.4.7 Middle East & Africa Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 12.4.8 Middle East & Africa Hemophilia Treatment Market, by Country, 2019 & 2027 (%)
    • 12.4.9 Saudi Arabia
      • 12.4.9.1 Saudi Arabia Hemophilia Treatment Market, Revenue and Forecast to 2027 (US$ Mn)
      • 12.4.9.2 Saudi Arabia Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
        • 12.4.9.2.1 Saudi Arabia Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 12.4.9.2.2 Saudi Arabia Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 12.4.9.3 Saudi Arabia Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
      • 12.4.9.4 Saudi Arabia Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
      • 12.4.9.5 Saudi Arabia Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
      • 12.4.9.6 Saudi Arabia Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 12.4.10 UAE
      • 12.4.10.1 UAE Hemophilia Treatment Market, Revenue and Forecast to 2027 (US$ Mn)
        • 12.4.10.1.1 UAE Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 12.4.10.1.2 UAE Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 12.4.10.2 UAE Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
      • 12.4.10.3 UAE Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
      • 12.4.10.4 UAE Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
      • 12.4.10.5 UAE Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 12.4.11 South Africa
      • 12.4.11.1 South Africa Hemophilia Treatment Market, Revenue and Forecast to 2027 (US$ Mn)
      • 12.4.11.2 South Africa Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
        • 12.4.11.2.1 South Africa Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 12.4.11.2.2 South Africa Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 12.4.11.3 South Africa Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
      • 12.4.11.4 South Africa Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
      • 12.4.11.5 South Africa Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
      • 12.4.11.6 South Africa Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • 12.5 South And Central America: Hemophilia Treatment Market
    • 12.5.1 South and Central America Hemophilia Treatment Market, Revenue and Forecast to 2027 (US$ Mn)
    • 12.5.2 South and Central America Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 12.5.2.1 South and Central America Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 12.5.2.2 South and Central America Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
    • 12.5.3 South and Central America Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
    • 12.5.4 South and Central America Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
    • 12.5.5 South and Central America Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
    • 12.5.6 South and Central America Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 12.5.7 South and Central America Hemophilia Treatment Market, by Country, 2019 & 2027 (%)
    • 12.5.8 Brazil
      • 12.5.8.1 Brazil Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
      • 12.5.8.2 Brazil Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
        • 12.5.8.2.1 Brazil Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 12.5.8.2.2 Brazil Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 12.5.8.3 Brazil Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
      • 12.5.8.4 Brazil Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
      • 12.5.8.5 Brazil Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
      • 12.5.8.6 Brazil Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 12.5.9 Argentina
      • 12.5.9.1 Argentina Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
      • 12.5.9.2 Argentina Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
        • 12.5.9.2.1 Argentina Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 12.5.9.2.2 Argentina Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 12.5.9.3 Argentina Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
      • 12.5.9.4 Argentina Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
      • 12.5.9.5 Argentina Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
      • 12.5.9.6 Argentina Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)

13. Global Hemophilia Treatment Market - Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies Done By the Companies in the Market, (%)
  • 13.3 Organic Developments Done By The Companies in The Market
  • 13.4 Inorganic Developments Done by The Companies In The Market

14. COMPANY PROFILES

  • 14.1 Bayer AG
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Sanofi
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 F. Hoffmann-La Roche Ltd
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Kedrion S.p.A
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 CSL Limited
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 Biotest AG.
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 Pfizer Inc.
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.8 Novo Nordisk A/S
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments
  • 14.9 Octapharma AG
    • 14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Products and Services
    • 14.9.4 Financial Overview
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Developments
  • 14.10 Baxter International Inc.
    • 14.10.1 Key Facts
    • 14.10.2 Business Description
    • 14.10.3 Products and Services
    • 14.10.4 Financial Overview
    • 14.10.5 SWOT Analysis
    • 14.10.6 Key Developments

15. Appendix

  • 15.1 About The Insight Partners
  • 15.2 Glossary of Terms

LIST OF TABLES

  • Table 1. Prevalence of Hemophilia Across a Few Countries:
  • Table 2. North America Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 3. North America Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 4. North America Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 5. North America Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
  • Table 6. North America Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
  • Table 7. North America Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
  • Table 8. North America Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 9. US Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 10. US Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 11. US Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 12. US Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
  • Table 13. US Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
  • Table 14. US Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
  • Table 15. US Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 16. Canada Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 17. Canada Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 18. Canada Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 19. Canada Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
  • Table 20. Canada Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
  • Table 21. Canada Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
  • Table 22. Canada Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 23. Mexico Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 24. Mexico Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 25. Mexico Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 26. Mexico Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
  • Table 27. Mexico Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
  • Table 28. Mexico Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
  • Table 29. Mexico Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 30. Europe Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 31. Europe Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 32. Europe Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 33. Europe Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
  • Table 34. Europe Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
  • Table 35. Europe Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
  • Table 36. Europe Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 37. Germany Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 38. Germany Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 39. Germany Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 40. Germany Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
  • Table 41. Germany Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
  • Table 42. Germany Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
  • Table 43. Germany Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 44. Products Used to Treat Haemophilia A (including inhibitors) between April 2015 & March 2016
  • Table 45. Products Used to Treat Haemophilia B (including inhibitors) between April 2015 & March 2016
  • Table 46. UK Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 47. UK Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 48. UK Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 49. UK Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
  • Table 50. UK Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
  • Table 51. UK Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
  • Table 52. UK Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 53. France Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 54. France Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 55. France Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 56. France Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
  • Table 57. France Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
  • Table 58. France Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
  • Table 59. France Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 60. Spain Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 61. Spain Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 62. Spain Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 63. Spain Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
  • Table 64. Spain Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
  • Table 65. Spain Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
  • Table 66. Spain Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 67. Italy Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 68. Italy Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 69. Italy Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 70. Italy Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
  • Table 71. Italy Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
  • Table 72. Italy Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
  • Table 73. Italy Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 74. Asia Pacific Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 75. Asia Pacific Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 76. Asia Pacific Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 77. Asia Pacific Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
  • Table 78. Asia Pacific Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
  • Table 79. Asia Pacific Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
  • Table 80. Asia Pacific Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 81. Japan Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 82. Japan Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 83. Japan Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 84. Japan Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
  • Table 85. Japan Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
  • Table 86. Japan Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
  • Table 87. Japan Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 88. China Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 89. China Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 90. China Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 91. China Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
  • Table 92. China Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
  • Table 93. China Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
  • Table 94. China Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 95. India Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 96. India Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 97. India Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 98. India Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
  • Table 99. India Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
  • Table 100. India Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
  • Table 101. India Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 102. South Korea Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 103. South Korea Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 104. South Korea Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 105. South Korea Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
  • Table 106. South Korea Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
  • Table 107. South Korea Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
  • Table 108. South Korea Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 109. Australia Hemophilia Treatment Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 110. Australia Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 111. Australia Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 112. Australia Hemophilia Treatment Market, by Disease- Revenue and Forecast to 2027 (USD Million)
  • Table 113. Australia Hemophilia Treatment Market, by Treatment Type- Revenue and Forecast to 2027 (USD Million)
  • Table 114. Australia Hemophilia Treatment Market, by Therapy- Revenue and Forecast to 2027 (USD Million)
  • Table 115. Australia Hemophilia Treatment Market, by End User- Revenue and Forecast to 2027 (USD Million)
  • Table 116. Middle East & Africa Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 117. Middle East & Africa Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 118. Middle East & Africa Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 119. Middle East & Africa Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
  • Table 120. Middle East & Africa Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
  • Table 121. Middle East & Africa Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
  • Table 122. Middle East & Africa Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 123. Saudi Arabia Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 124. Saudi Arabia Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 125. Saudi Arabia Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 126. Saudi Arabia Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
  • Table 127. Saudi Arabia Hemophilia Treatment Market, by Treatment Type- Revenue and Forecast to 2027 (USD Million)
  • Table 128. Saudi Arabia Hemophilia Treatment Market, by Therapy- Revenue and Forecast to 2027 (USD Million)
  • Table 129. Saudi Arabia Hemophilia Treatment Market, by End User- Revenue and Forecast to 2027 (USD Million)
  • Table 130. UAE Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 131. UAE Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 132. UAE Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 133. UAE Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 134. UAE Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
  • Table 135. UAE Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
  • Table 136. UAE Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
  • Table 137. UAE Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 138. South Africa Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 139. South Africa Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 140. South Africa Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 141. South Africa Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
  • Table 142. South Africa Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
  • Table 143. South Africa Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
  • Table 144. South Africa Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 145. South and Central America Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 146. South and Central America Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 147. South and Central America Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 148. South and Central America Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
  • Table 149. South and Central America Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
  • Table 150. South and Central America Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
  • Table 151. South and Central America Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 152. Population Data of the Brazil Showing Number of People with Hemophilia
  • Table 153. Brazil Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 154. Brazil Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 155. Brazil Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 156. Brazil Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
  • Table 157. Brazil Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
  • Table 158. Brazil Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
  • Table 159. Brazil Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 160. Argentina Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 161. Argentina Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 162. Argentina Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 163. Argentina Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
  • Table 164. Argentina Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
  • Table 165. Argentina Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
  • Table 166. Argentina Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 167. Organic Developments Done by The Companies
  • Table 168. Inorganic Developments Done by The Companies
  • Table 169. Glossary of Terms, Hemophilia Treatment Market

LIST OF FIGURES

  • Figure 1. Hemophilia Treatment Market Segmentation
  • Figure 2. Hemophilia Treatment Segmentation, by Region
  • Figure 3. Global Hemophilia Treatment Market Overview
  • Figure 4. Plasma Derived Coagulation Factor Concentrates Held Largest Share Of Product Segment In Hemophilia Treatment Market
  • Figure 5. Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 6. Global Hemophilia Treatment Market, By Geography (US$ Mn)
  • Figure 7. Global Hemophilia Treatment Market- Leading Country Markets (US$ Mn)
  • Figure 8. Global Hemophilia Treatment Market, Industry Landscape
  • Figure 9. North America PEST Analysis
  • Figure 10. Hemophilia Treatment Market in Europe: PEST Analysis
  • Figure 11. Hemophilia Treatment Market In APAC: PEST Analysis
  • Figure 12. Hemophilia Treatment Market in MEA: PEST Analysis
  • Figure 13. South & Central America PEST Analysis
  • Figure 14. Hemophilia Treatment Market Impact Analysis of Drivers and Restraints
  • Figure 15. Global Hemophilia Treatment Market - Revenue Forecast and Analysis 2019- 2027 (US$ Million)
  • Figure 16. Global Hemophilia Treatment Market - By Geography Forecast And Analysis - 2019- 2027
  • Figure 17. Prominent Players in the Hemophilia Treatment Market
  • Figure 18. Hemophilia Treatment Market Revenue Share, by Product (2019 and 2027)
  • Figure 19. Plasma-Derived Coagulation Factor Concentrates: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 20. Factor VIII: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 21. Factor IX: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 22. Factor XII: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 23. Activated Prothrombin Complex Concentrates: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 24. Von Willebrand Factor: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 25. Recombinant Coagulation Factor Concentrates: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 26. Factor VIII: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 27. Factor IX: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 28. Desmopressin: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 29. Antifibrinolytic Agents: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 30. Global Hemophilia Treatment Market, by Disease 2019 and 2027 (%)
  • Figure 31. Hemophilia A: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 32. Hemophilia B: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 33. Hemophilia C: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 34. Hemophilia Treatment Market Revenue Share, by Treatment Type (2019 and 2027)
  • Figure 35. Prophylaxis: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 36. On-demand: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 37. Global Hemophilia Treatment Market, by Therapy 2019 and 2027 (%)
  • Figure 38. Replacement Therapy: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 39. ITI Therapy: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 40. Gene Therapy: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 41. Global Hemophilia Treatment Market, by End User 2019 and 2027 (%)
  • Figure 42. Hospitals & Clinics: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 43. Hemophilia Treatment Centers: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 44. Ambulatory Surgical Centers: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 45. North America Hemophilia Treatment Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 46. North America Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 47. North America Hemophilia Treatment Market, by Country, 2019 & 2027 (%)
  • Figure 48. US Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 49. Canada Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 50. Mexico Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 51. Europe Hemophilia Treatment Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 52. Europe Hemophilia Treatment Market Revenue and Forecast to 2027 (US$ Mn)
  • Figure 53. Europe Hemophilia Treatment Market, by Country, 2019 & 2027 (%)
  • Figure 54. Germany Hemophilia Treatment Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 55. UK Hemophilia Treatment Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 56. France Hemophilia Treatment Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 57. Spain Hemophilia Treatment Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 58. Italy Hemophilia Treatment Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 59. Asia Pacific Hemophilia Treatment Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 60. Asia Pacific Hemophilia Treatment Market Revenue and Forecast to 2027 (US$ Mn)
  • Figure 61. Asia Pacific Hemophilia Treatment Market, by Country, 2019 & 2027 (%)
  • Figure 62. Japan Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 63. China Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 64. India Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 65. South Korea Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 66. Australia Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 67. Middle East & Africa Hemophilia Treatment Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 68. Middle East & Africa Hemophilia Treatment Market Revenue and Forecast to 2027 (US$ Mn)
  • Figure 69. Middle East & Africa Hemophilia Treatment Market, by Country, 2019 & 2027 (%)
  • Figure 70. Saudi Arabia Hemophilia Treatment Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 71. UAE Hemophilia Treatment Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 72. South Africa Hemophilia Treatment Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 73. South and Central America Hemophilia Treatment Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 74. South and Central America Hemophilia Treatment Market Revenue and Forecast to 2027 (US$ Mn)
  • Figure 75. South and Central America Hemophilia Treatment Market, by Country, 2019 & 2027 (%)
  • Figure 76. Brazil Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 77. Argentina Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 78. Growth Strategies Done By the Companies in the Market, (%)